|
#Unite2FightCorona #IndiaFightsCorona
PRESS INFORMATION BUREAU
MINISTRY OF INFORMATION & BROADCASTING
GOVERNMENT OF INDIA
*****
India’s Cumulative COVID-19 Vaccination Coverage exceeds 181.56 Cr
More than 34 lakh vaccine doses administered for age group 12-14 years
India’s Active caseload declines to 23,913 today; stands at 0.06% of India’s total Positive Cases
1,581 new cases reported in the last 24 hours
Recovery Rate currently stands at 98.74%
Weekly Positivity Rate is presently at 0.39%
India’s COVID-19 vaccination coverage has exceeded 181.56 Cr (1,81,56,01,944) as per provisional reports till 7 am today. This has been achieved through 2,14,38,677 sessions.
COVID-19 vaccination for the age group 12-14 years was started on 16 March, 2022. So far, more than 34 lakh (34,19,633) adolescents have been administered with the first dose of COVID-19 vaccine.
The break-up of the cumulative figure as per the provisional report till 7 am today include:
| Cumulative Vaccine Dose Coverage | ||
| HCWs | 1st Dose | 10403113 |
| 2nd Dose | 9991704 | |
| Precaution Dose | 4369373 | |
| FLWs | 1st Dose | 18412260 |
| 2nd Dose | 17490858 | |
| Precaution Dose | 6684262 | |
| Age Group 12-14 years | 1st Dose | 3419633 |
| Age Group 15-18 years | 1st Dose | 56294499 |
| 2nd Dose | 35814910 | |
| Age Group 18-44 years | 1st Dose | 553873437 |
| 2nd Dose | 460202340 | |
| Age Group 45-59 years | 1st Dose | 202626402 |
| 2nd Dose | 183959784 | |
| Over 60 years | 1st Dose | 126652374 |
| 2nd Dose | 114583223 | |
| Precaution Dose | 10823772 | |
| Precaution Dose | 2,18,77,407 | |
| Total | 1,81,56,01,944 | |
Following a continuous downward trend, India’s Active Caseload has declined to 23,913 today, constituting 0.06% of the country’s total Positive Cases.
Consequently, India’s recovery rate stands at 98.74%. 2,741 patients have recovered in the last 24 hours and the cumulative tally of recovered patients (since the beginning of the pandemic) is now at 4,24,70,515.
1,581 new cases were reported in the last 24 hours.
The last 24 hours saw a total of 5,68,471 COVID-19 tests being conducted. India has so far conducted over 78.36 Cr (78,36,13,628) cumulative tests.
There has been a sustained fall in the weekly and daily Positivity Rates too. Weekly Positivity Rate in the country currently stands at 0.39% and the Daily Positivity rate is also reported to be 0.28%.
https://www.pib.gov.in/PressReleasePage.aspx?PRID=1807957
Update on COVID-19 Vaccine Availability in States/UTs
More than 183.62 Crore vaccine doses provided to States/UTs
More than 17.02 Crore balance and unutilized vaccine doses still available with States/UTs
The Union Government is committed to accelerating the pace and expanding the scope of COVID-19 vaccination throughout the country. The nationwide COVID 19 vaccination started on 16th January 2021. The new phase of universalization of COVID-19 vaccination commenced from 21st June 2021. The vaccination drive has been ramped up through availability of more vaccines, advance visibility of vaccine availability to States and UTs for enabling better planning by them, and streamlining the vaccine supply chain.
As part of the nationwide vaccination drive, Government of India has been supporting the States and UTs by providing them COVID Vaccines free of cost. In the new phase of the universalization of the COVID19 vaccination drive, the Union Government will procure and supply (free of cost) 75% of the vaccines being produced by the vaccine manufacturers in the country to States and UTs.
| VACCINE DOSES |
(As on 22nd March 2022) |
|
SUPPLIED |
1,83,62,27,980 |
|
BALANCE AVAILABLE
|
17,02,22,816 |
More than 183.62 crore (1,83,62,27,980) vaccine doses have been provided to States/UTs so far through Govt. of India (free of cost channel) and through direct state procurement category.
More than 17.02 Cr (17,02,22,816) balance and unutilized COVID Vaccine doses are still available with the States/UTs to be administered.
https://www.pib.gov.in/PressReleasePage.aspx?PRID=1807956
EXORBITANT PRICES BEING CHARGED BY VACCINE MANUFACTURES
The Covaxin and Covishield are two different types of Covid-19 vaccine and their manufacturing processes are also different. The price of vaccine for procurement by Government of India is negotiated by National Expert Group on Vaccine Administration for COVID-19 (NEGVAC) and its subgroups involving detailed deliberations with the vaccine manufacturers. Under National COVID-19 Vaccination Programme, COVID-19 vaccine is available free of cost at Government COVID-19 Vaccination Centres (CVCs) to all eligible beneficiaries irrespective of their socio-economic status.
The vaccine manufacturers are free to fix the price of vaccine for procurement by Private Hospitals which has to be declared in a transparent manner. However, Government of India has fixed a maximum service charge of INR 150 per dose over and above the price of vaccine for vaccine administration at Private COVID-19 Vaccination Centres (CVCs). State Governments have been advised to monitor the price charged at the private hospitals.
https://www.pib.gov.in/PressReleasePage.aspx?PRID=1808229
TWEET LINKS
India has shown the way.
A prepared India is a prepared world.
India’s response makes the world’s fight successful: Dr Roderico Ofrin, Country Representative, @WHO
#COVIDLessonsFromIndia pic.twitter.com/xDRU5WubRE— Dr Mansukh Mandaviya (@mansukhmandviya) March 22, 2022
#LargestVaccineDrive#Unite2FightCorona pic.twitter.com/t6NWh7BW0v
— Ministry of Health (@MoHFW_INDIA) March 22, 2022
